Wall Street Analysts See a 26.27% Upside in Travere (TVTX): Can the Stock Really Move This High?

Travere Therapeutics (TVTX) closed the last trading session at $17.97, gaining 23.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22.69 indicates a 26.3% upside potential. The mean estimate comprises 16 short-term price targets with a standard deviation of $8.48. While the lowest estimate of $12 indicates a 33.2% decline from the current price level, the most optimistic analyst ...